OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SILO
Silo Pharma, Inc.
There isn't enough reported data to score SILO yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
SILO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
SILO's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
SILO PE Valuation
SILO has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
SILO Forward outlook
There aren't enough analyst estimates for SILO to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the stronger earnings trend. Trailing diluted EPS is up 147% for OSCR versus SILO down 177%.
SILO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$13.80 | +$4.07 |
| Q2 2025 | -$15.30 | +$2.42 |
| Q1 2025 | -$17.10 | +$0.77 |
| Q4 2024 | -$17.85 | +$0.17 |
| Q3 2024 | -$17.87 | +$12.45 |
| Q2 2024 | -$17.72 | +$16.80 |
| Q1 2024 | -$17.87 | +$19.35 |
| Q4 2023 | -$18.02 | +$14.85 |
SILO is still losing money, but far less than before: $13.80 per share over the past year, against $52.50 at its worst in mid-2020.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over SILO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
SILO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $18K | 0% |
| Q4 2025 | $18K | 0% |
| Q3 2025 | $18K | 0% |
| Q2 2025 | $18K | 0% |
| Q1 2025 | $18K | 0% |
| Q4 2024 | $18K | 0% |
| Q3 2024 | $18K | 0% |
| Q2 2024 | $18K | 0% |
SILO's revenue has slid since its 2021 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -8846% | -2777 points |
| Q4 2025 | -4363% | +5696 points |
| Q3 2025 | -6388% | -785 points |
| Q2 2025 | -6927% | -1364 points |
| Q1 2025 | -6070% | -1191 points |
| Q4 2024 | -10060% | -3604 points |
| Q3 2024 | -5604% | -1313 points |
| Q2 2024 | -5563% | +623 points |
SILO's operating margin was −8846% last quarter, down 2777 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over SILO on cash generation, producing positive trailing cash flow while its opponent burns cash.
SILO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$781.9K | +$503.4K |
| Q1 2026 | -$822.6K | +$817.7K |
| Q4 2025 | -$780.3K | +$137.2K |
| Q3 2025 | -$955.5K | +$391K |
| Q2 2025 | -$1.3M | -$553.5K |
| Q1 2025 | -$1.6M | -$802.1K |
| Q4 2024 | -$917.4K | -$7.4K |
| Q3 2024 | -$1.3M | -$274.7K |
SILO has burned cash in almost every quarter: −$3M over the past year, against −$5M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over SILO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SILO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +20% | +185K shares |
| 1 year | +267% | +800K shares |
| 3 years | +422% | +888K shares |
| 5 years | +876% | +986K shares |
| Available history | +3411% | +1.1M shares |
SILO has 1M diluted shares, up 267% from a year ago.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
SILO Net Leverage
SILO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
SILO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.7 | Neutral |
| Stochastic | 12.9 | Oversold |
SILO's weekly RSI is 35 (neutral) and its Stochastic is 13 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
SILO PE vs Healthcare Sector
| Metric | SILO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SILO has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over SILO on trend strength, trading above more of its moving averages.
SILO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.44 | 33% above |
| 20 week MA | $2.77 | 31% below |
| 50 week MA | $4.58 | 58% below |
| 100 week MA | $8.91 | 79% below |
| 200 week MA | $17.4 | 89% below |
SILO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 89% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over SILO on returns for 2026, with the stronger performance.
SILO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $262.5 | $101.3 | -61% |
| 2022 | $101.3 | $45.0 | -56% |
| 2023 | $45.0 | $21.6 | -52% |
| 2024 | $21.6 | $14.1 | -35% |
| 2025 | $14.1 | $5.47 | -61% |
| 2026 YTD | $5.47 | $1.91 | -65% |
SILO has finished every year since 2021 lower, and it's down 65% so far in 2026.